NCT01954134

P53 in Differentiated Thyroid Cancer

P53 Antibody; Is it an Indicator of Dedifferentiated Thyroid Cancer?

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 199 (actual)
• Sponsor: Cumhuriyet University · Academic / Other
• Sex: All
• Age: 16 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

In clinical practise patients with negative radioiodine scan with positive tyhroglobulin is considered as radioiodine resistant or in another words in the process of dedifferentiation. The aim of the present study was to search a simple blood test that could lead to early identification of patients with dedifferentiation. In this respect, we investigate whether the serum level of anti-p53 antibody has the diagnostic value in the follow-up of patients with high levels of thyroglobulin (tg) and negative I-131 scan.

Detailed description

In the present study enrolled were 171 patients with mean age of 47.7±13.5 yrs (range; 16-80yrs) and 28 healthy subjects with an age range of 18-52 yrs (mean: 36.0±9.8 yrs). 134 (78.4%) patients were female and 37 (21.6%) patients were male.

Conditions

• Thyroid Neoplasms

Timeline

• Start date: 2010-12-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2013-10-01
• Last updated: 2013-10-01

Locations

1 site across 1 country: Turkey (Türkiye)